Technology | Angiography | October 05, 2016

Toshiba Introduces Infinix-i Sky + Double Sliding C-arm

Ceiling-mounted system delivers 3-D imaging anywhere to enhance workflow

Toshiba America Medical Systems, Infinix-i Sky + double sliding C-arm, RSNA 2016

October 5, 2016 — Interventional labs now have an imaging system that provides clinicians flexibility to perform a wide array of procedures with the launch of Toshiba’s Infinix-i Sky +*. The ceiling-mounted system features a double sliding C-arm and 12 x 16-inch flat panel, offering clinicians the potential to increase coverage, speed and patient access.

The C-arm design delivers numerous clinical benefits to interventional radiologists and vascular surgeons. Those include:

  • 3-D imaging anywhere: The new system can deliver 3-D imaging anywhere with 210 degrees of anatomical coverage on both the right and left side of the patient, and a high-speed 3-D rotation of 80 degrees per second;
  • Image over or under the table: The Infinix-i Sky + is capable of having its C-arm in a lateral position over or under the table, enabling clinicians to prioritize versatility and safety, particularly in a sterile OR environment;
  • PA/AP C-arm flip: By allowing the flat panel detector to be positioned above or below the patient, the system offers increased flexibility for procedures that require additional space, including long needle biopsies, aspirations and vertebroplasty;
  • Low contrast imaging: The double sliding C-arm system mechanics supports low contrast imaging from the head-end or either side of the patient; and
  • Head-end Access Halo: Ensuring positioning is never a hassle for clinicians, the system’s Access Halo offers 270-degree C-arm rotation that allows for easy head-end access.

The Infinix-i Sky + incorporates an extensive set of automated and user-selectable dose management tools, designed to help clinicians minimize X-ray exposure. This includes technology like the Dose Tracking System that estimates peak skin dose exposure in real time.

For more information: www.medical.toshiba.com

*The Infinix-i Sky  + is the INFX-8000C (with CAS-930A C-arm).

Related Content

Synergy stent, abluminal polymer DES, bioresorbable polymer DES, bioresorbable polymer metallic stent

The Synergy stent is the first FDA cleared drug-eluting stent to use a bioresorbable polymer drug carrier. When the polymer dissolves after about four months, the devices become a bare metal stent. The technology is supposed to reduce the rate of late stent thrombosis due to vessel inflammation caused by durable polymers.

Feature | Stents Bioresorbable| January 17, 2017 | Dave Fornell
One of the big advancements in drug-eluting stent (DES) technology has been the development of bioresorbable polymers
Medtronic, CoreValve Evolut R TAVR system, U.S. IDE Study, TCT 2016
News | Heart Valve Technology| November 03, 2016
Medtronic plc unveiled new clinical data showing that patients treated with the self-expanding CoreValve Evolut R...
congenital heart patients, cardiac cath lab, anesthesia sedation practices, joint document, SCAI, SPA, CCAS
News | Congenital Heart| November 03, 2016
The Society for Cardiovascular Angiography and Interventions (SCAI), the Society for Pediatric Anesthesia (SPA) and the...
open-heart surgery, PCI, percutaneous coronary intervention, NOBLE trial, left main coronary artery disease, LMCAD, TCT 2016
News | Cardiovascular Surgery| November 03, 2016
Coronary artery bypass (CABG) surgery is the standard treatment for revascularization in patients with left main...
SENTINEL trial, transcatheter embolic protection, TCEP, TAVR, stroke, TCT 2016
News | Embolic Protection Devices| November 03, 2016
An international study has found that transcatheter cerebral embolic protection (TCEP) is safe, provides effective...
News | Drug-Eluting Balloons| November 03, 2016
The Spectranetics Corp. announced that it has submitted to the U.S. Food & Drug Administration (FDA) its Pre-Market...
RESPECT trial, Amplatzer PFO Occluder, St. Jude Medical, TCT 2016
News | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced the long-term data from RESPECT, a landmark trial, during a First Report session at the...
Medtronic, Resolute Integrity DES, drug-eluting stent, BIO-RESORT study, TCT 2016
News | Stents Drug Eluting| November 02, 2016
Investigators recently unveiled clinical data from the independent BIO-RESORT study, representing the first all-comers...
Medtronic, Harmony TPV, transcatheter pulmonary valve, clinical study results, TCT 2016
News | Heart Valve Technology| November 02, 2016
Medtronic plc recently announced new clinical data for the Harmony Transcatheter Pulmonary Valve (TPV) from its early...
St. Jude Medical, Amplatzer PFO Occluder, FDA approval, U.S. launch
Technology | Structural Heart Occluders| November 02, 2016
St. Jude Medical Inc. announced this week the U.S. Food and Drug Administration (FDA) approval and launch of the...
Overlay Init